Schedule 13G ownership disclosure
Avidity Biosciences Inc
Common Stock · CUSIP: 05370A108
Event date: 2025-09-30
- Filing-level shares
- 13,219,759
- Percent of class
- 9.57%
- The Vanguard Group
Shares: 13,219,759 · Class: 9.57%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-25-000039
- Form type
- SCHEDULE 13G/A
- Filer
- Avidity Biosciences, Inc.
- CIK
- CIK 1599901
- Filed
- Oct 30, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership